Suchergebnisse - "van Vloten, Jacob"

PubPharm (27)

1

Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer

enthalten in: Frontiers in microbiology | 2024

von Santry, L. | van Vloten, J. | AuYeung, A. | +7

2

Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer

enthalten in: Molecular therapy oncolytics | 2023

von Minott, J. | van Vloten, J. | Yates, J. | +10

3

A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2023

von Thomas, S. | Domm, J. | van Vloten, J. | +18

4

Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy

enthalten in: Research square | 2023

von Vile, R. | Webb, M. | van Vloten, J. | +12

5

CDK4/6 inhibition and dsRNA sensor agonism co-operate to enhance anti-cancer effects through ER stress and immune modulation of tumour cells

enthalten in: bioRxiv.org | 2022

von Roulstone, V. | Kyula, J. | Wright, J. | +27

6

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy

enthalten in: Cells | 2022

von Minott, J. | van Vloten, J. | Chan, L. | +3

7

Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

enthalten in: Science translational medicine | 2022

von Evgin, L. | Kottke, T. | Tonne, J. | +18

8

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von van Vloten, J. | Matuszewska, K. | Minow, M. | +12

9

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma

enthalten in: Biomedicines | 2022

von Stegelmeier, A. | Santry, L. | Guilleman, M. | +16

10

Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies

enthalten in: Frontiers in immunology | 2022

von Minott, J. | van Vloten, J. | Yates, J. | +7